Yang H, Zahan M, Hwang D, Prakash R, Ravi D, Hong I
Int J Mol Sci. 2025; 26(4).
PMID: 40004009
PMC: 11855533.
DOI: 10.3390/ijms26041534.
Karthikeyan S, Nallasamy P, Cleveland J, Arulmani A, Raveendran A, Karimi M
Redox Biol. 2025; 81:103525.
PMID: 39986116
PMC: 11893311.
DOI: 10.1016/j.redox.2025.103525.
Yang J
Cells. 2025; 14(3).
PMID: 39936946
PMC: 11817359.
DOI: 10.3390/cells14030154.
Beetler D, Giresi P, Di Florio D, Fliess J, McCabe E, Watkins M
Front Immunol. 2025; 15():1468969.
PMID: 39835120
PMC: 11743460.
DOI: 10.3389/fimmu.2024.1468969.
Mairuae N, Noisa P, Palachai N
Molecules. 2025; 29(24.
PMID: 39770133
PMC: 11677370.
DOI: 10.3390/molecules29246046.
A Meta-analysis of the Risk of Adverse Cardiovascular Events in Patients with Cancer Treated with Inhibitors of the PI3K/AKT/mTOR Signaling Pathway.
Liang X, Zhang C, Tang Y, Li Y, Zhu Z, Qiu T
Cardiovasc Toxicol. 2024; 25(2):269-281.
PMID: 39521735
DOI: 10.1007/s12012-024-09933-7.
The role and mechanism of NRG1/ErbB4 in inducing the differentiation of induced pluripotent stem cells into cardiomyocytes.
Li X, Zhang H, Li W, Tuo H, He B, Jiang H
BMC Cardiovasc Disord. 2024; 24(1):559.
PMID: 39407109
PMC: 11481795.
DOI: 10.1186/s12872-024-04224-z.
Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway.
Zhao M, Feng L, Li W
Drug Des Devel Ther. 2024; 18:4529-4550.
PMID: 39399124
PMC: 11471080.
DOI: 10.2147/DDDT.S480248.
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.
Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C
Signal Transduct Target Ther. 2024; 9(1):234.
PMID: 39289339
PMC: 11408715.
DOI: 10.1038/s41392-024-01931-z.
Sex Differences in Expression of Pro-Inflammatory Markers and miRNAs in a Mouse Model of CVB3 Myocarditis.
Estepa M, Niehues M, Vakhrusheva O, Haritonow N, Ladilov Y, Barcena M
Int J Mol Sci. 2024; 25(17).
PMID: 39273613
PMC: 11395254.
DOI: 10.3390/ijms25179666.
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.
Ashayeri Ahmadabad H, Mohammadi Panah S, Ghasemnejad-Berenji H, Ghojavand S, Ghasemnejad-Berenji M, Khezri M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1035-1055.
PMID: 39225830
DOI: 10.1007/s00210-024-03358-3.
mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus.
Zare A, Khosropanah S, Daryabor G, Doroudchi M
BMC Endocr Disord. 2024; 24(1):162.
PMID: 39198757
PMC: 11361055.
DOI: 10.1186/s12902-024-01703-4.
The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma.
Jiang Q, Xiao J, Hsieh Y, Kumar N, Han L, Zou Y
Biomedicines. 2024; 12(7).
PMID: 39062182
PMC: 11274428.
DOI: 10.3390/biomedicines12071610.
Regulation of bone homeostasis: signaling pathways and therapeutic targets.
Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M
MedComm (2020). 2024; 5(8):e657.
PMID: 39049966
PMC: 11266958.
DOI: 10.1002/mco2.657.
Silencing DOCK2 Attenuates Cardiac Fibrosis Following Myocardial Infarction in Mice Via Targeting PI3K/Akt and Wnt/β-Catenin Pathways.
Hu G, Chen J, Chen M, Yang K, Wang Y, Ma Z
J Cardiovasc Transl Res. 2024; 17(6):1442-1454.
PMID: 38990461
DOI: 10.1007/s12265-024-10533-7.
Stem cell therapy as a promising approach for ischemic stroke treatment.
Yaqubi S, Karimian M
Curr Res Pharmacol Drug Discov. 2024; 6:100183.
PMID: 38831867
PMC: 11144755.
DOI: 10.1016/j.crphar.2024.100183.
Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives.
Ovchinnikov A, Potekhina A, Arefieva T, Filatova A, Ageev F, Belyavskiy E
Int J Mol Sci. 2024; 25(9).
PMID: 38732177
PMC: 11084261.
DOI: 10.3390/ijms25094958.
Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids.
Song M, Choi D, Im J, Song Y, Kim J, Lee H
Cell Death Dis. 2024; 15(5):308.
PMID: 38693114
PMC: 11063052.
DOI: 10.1038/s41419-024-06703-9.
Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.
Alobaid S, Alshahrani R, Alonazi A, Alrasheed N, Alamin M, Alshammari T
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543160
PMC: 10975938.
DOI: 10.3390/ph17030374.
Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines.
Lai W, Wang B, Huang R, Zhang C, Fu P, Ma L
J Transl Int Med. 2024; 12(1):22-34.
PMID: 38525436
PMC: 10956731.
DOI: 10.2478/jtim-2023-0137.